Antigens for pre-erythrocytic malaria vaccines: Building on success

Parasite Immunology

Volumn 31, Issue 9, 2009, Pages 539-546

  Speake, C ^a,b   Duffy, P E ^a,b  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Malaria; Plasmodium; Pre erythrocytic; Vaccines

Indexed keywords

ANTIGEN; AS01E VACCINE; AS02 VACCINE; CHLOROQUINE; DNA VACCINE; ERYTHROCYTE ANTIGEN; ERYTHROCYTE ANTIGEN VACCINE; LIVER ANTIGEN; MALARIA VACCINE; RECOMBINANT VACCINE; RTS,S VACCINE; SPOROZOITE VACCINE; UNCLASSIFIED DRUG; VACCINE;

ADJUVANT THERAPY; ATTENUATION; CELLULAR IMMUNITY; CLINICAL ASSESSMENT; CLINICAL TRIAL; DISEASE COURSE; DNA IMMUNIZATION; DRUG EFFICACY; DRUG SCREENING; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSPOT ASSAY; ERYTHROCYTE; FLOW CYTOMETRY; FUNCTIONAL GENOMICS; GENOMICS; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; INNATE IMMUNITY; KENYA; LIVER; LONG TERM CARE; MALARIA; NONHUMAN; PARASITE; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SPOROZOITE; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTIGENS, PROTOZOAN; DISEASE MODELS, ANIMAL; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; RODENTIA;

ANIMALIA; PLASMODIUM FALCIPARUM; RODENTIA;

EID: 68949117521     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2009.01139.x     Document Type: Review

References (64)

1. Doolan DL Martinez-Alier N. Immune response to pre-erythrocytic stages of malaria parasites. Curr Mol Med 2006 6 : 169 185.
2. Tarun AS, Baer K, Dumpit RF, et al. Quantitative isolation and in vivo imaging of malaria parasite liver stages. Int J Parasitol 2006 36 : 1283 1293.
3. Sattabongkot J, Yimamnuaychoke N, Leelaudomlipi S, et al. Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Am J Trop Med Hyg 2006 74 : 708 715.
4. Kaiser K, Camargo N Kappe SH. Transformation of sporozoites into early exoerythrocytic malaria parasites does not require host cells. J Exp Med 2003 197 : 1045 1050.
5. Medica DL Sinnis P. Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected anopheline mosquitoes. Infect Immun 2005 73 : 4363 4369.
6. Yamauchi LM, Coppi A, Snounou G Sinnis P. Plasmodium sporozoites trickle out of the injection site. Cell Microbiol 2007 9 : 1215 1222.
7. Nussenzweig RS, Vanderberg J, Most H Orton C. Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature 1967 216 : 160 162.
8. Clyde DF, Most H, McCarthy VC Vanderberg JP. Immunization of man against sporozite-induced falciparum malaria. Am J Med Sci 1973 266 : 169 177.
9. Luke TC Hoffman SL. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. J Exp Biol 2003 206 : 3803 3808.
10. Mueller AK, Camargo N, Kaiser K, et al. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc Natl Acad Sci USA 2005 102 : 3022 3027.
11. Mueller AK, Labaied M, Kappe SH Matuschewski K. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 2005 433 : 164 167.
12. Mikolajczak SA, Aly AS Kappe SH. Preerythrocytic malaria vaccine development. Curr Opin Infect Dis 2007 20 : 461 466.
13. van Schaijk BC, Janse CJ, van Gemert GJ, et al. Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes. PLoS ONE 2008 3 : e3549.
14. Aponte JJ, Aide P, Renom M, et al. Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial. Lancet 2007 370 : 1543 1551.
15. Alonso PL, Sacarlal J, Aponte JJ, et al. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. Lancet 2005 366 : 2012 2018.
16. Abdulla S, Oberholzer R, Juma O, et al. Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N Engl J Med 2008 359 : 2533 2544.
17. Bejon P, Lusingu J, Olotu A, et al. Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med 2008 359 : 2521 2532.
18. Lalvani A, Moris P, Voss G, et al. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine. J Infect Dis 1999 180 : 1656 1664.
19. Kumar KA, Sano G, Boscardin S, et al. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 2006 444 : 937 940.
20. Gruner AC, Mauduit M, Tewari R, et al. Sterile protection against malaria is independent of immune responses to the circumsporozoite protein. PLoS ONE 2007 2 : e1371.
21. McConkey SJ, Reece WH, Moorthy VS, et al. Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat Med 2003 9 : 729 735.
22. Moorthy VS, Imoukhuede EB, Milligan P, et al. A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults. PLoS Med 2004 1 : e33.
23. Bejon P, Mwacharo J, Kai O, et al. A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya. PLoS Clin Trials 2006 1 : e29.
24. Silvie O, Semblat JP, Franetich JF, Hannoun L, Eling W Mazier D. Effects of irradiation on Plasmodium falciparum sporozoite hepatic development: implications for the design of pre-erythrocytic malaria vaccines. Parasite Immunol 2002 24 : 221 223.
25. Renia L, Rodrigues MM Nussenzweig V. Intrasplenic immunization with infected hepatocytes: a mouse model for studying protective immunity against malaria pre-erythrocytic stage. Immunology 1994 82 : 164 168.
26. Scheller LF Azad AF. Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites. Proc Natl Acad Sci USA 1995 92 : 4066 4068.
27. Chen DH, Tigelaar RE Weinbaum FI. Immunity to sporozoite-induced malaria infeciton in mice. I. The effect of immunization of T and B cell-deficient mice. J Immunol 1977 118 : 1322 1327.
28. Schmidt NW, Podyminogin RL, Butler NS, et al. Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc Natl Acad Sci USA 2008 105 : 14017 14022.
29. Ferreira A, Schofield L, Enea V, et al. Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science 1986 232 : 881 884.
30. + T cells to sporozoite-induced protection against malaria. Immunology 1993 80 : 1 5.
31. + T-cell responses against malaria liver stages. Nat Med 2002 8 : 166 170.
32. + cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int Immunol 1991 3 : 579 585.
33. Weiss WR, Berzofsky JA, Houghten RA, Sedegah M, Hollindale M Hoffman SL. A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei. J Immunol 1992 149 : 2103 2109.
34. Charoenvit Y, Mellouk S, Cole C, et al. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites. J Immunol 1991 146 : 1020 1025.
35. Herrington D, Davis J, Nardin E, et al. Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. Am J Trop Med Hyg 1991 45 : 539 547.
36. Reece WH, Pinder M, Gothard PK, et al. A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat Med 2004 10 : 406 410.
37. Carlton JM, Adams JH, Silva JC, et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 2008 455 : 757 763.
38. Gardner MJ, Hall N, Fung E, et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002 419 : 498 511.
39. Pain A, Bohme U, Berry AE, et al. The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature 2008 455 : 799 803.
40. Carlton JM, Angiuoli SV, Suh BB, et al. Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature 2002 419 : 512 519.
41. Hall N, Karras M, Raine JD, et al. A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. Science 2005 307 : 82 86.
42. Winzeler EA. Malaria research in the post-genomic era. Nature 2008 455 : 751 756.
43. Wang Q, Brown S, Roos DS, Nussenzweig V Bhanot P. Transcriptome of axenic liver stages of Plasmodium yoelii. Mol Biochem Parasitol 2004 137 : 161 168.
44. Sacci JB Jr., Ribeiro JM, Huang F, et al. Transcriptional analysis of in vivo Plasmodium yoelii liver stage gene expression. Mol Biochem Parasitol 2005 142 : 177 183.
45. Siau A, Silvie O, Franetich JF, et al. Temperature shift and host cell contact up-regulate sporozoite expression of Plasmodium falciparum genes involved in hepatocyte infection. PLoS Pathog 2008 4 : e1000121.
46. Doolan DL, Southwood S, Freilich DA, et al. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc Natl Acad Sci USA 2003 100 : 9952 9957.
47. Tarun AS, Peng X, Dumpit RF, et al. A combined transcriptome and proteome survey of malaria parasite liver stages. Proc Natl Acad Sci USA 2008 105 : 305 310.
48. Singh AP, Buscaglia CA, Wang Q, et al. Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite. Cell 2007 131 : 492 504.
49. Haddad D, Bilcikova E, Witney AA, et al. Novel antigen identification method for discovery of protective malaria antigens by rapid testing of DNA vaccines encoding exons from the parasite genome. Infect Immun 2004 72 : 1594 1602.
50. Richards JS Beeson JG. The future for blood-stage vaccines against malaria. Immunol Cell Biol 2009 5 : 5.
51. Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V Zavala F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 1989 341 : 323 326.
52. + cytolytic T cell clone confers protection against murine malaria. J Exp Med 1990 172 : 1353 1357.
53. + T cells. J Infect Dis 2007 196 : 608 616.
54. Kumar KA, Baxter P, Tarun AS, Kappe SH Nussenzweig V. Conserved protective mechanisms in radiation and genetically attenuated uis3(-) and uis4(-) Plasmodium sporozoites. PLoS ONE 2009 4 : e4480.
55. Belnoue E, Costa FT, Frankenberg T, et al. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J Immunol 2004 172 : 2487 2495.
56. Putrianti ED, Silvie O, Kordes M, Borrmann S Matuschewski K. Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites. J Infect Dis 2009 199 : 899 903.
57. Belnoue E, Voza T, Costa FT, et al. Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage. J Immunol 2008 181 : 8552 8558.
58. Krzych U, Lyon JA, Jareed T, et al. T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens. J Immunol 1995 155 : 4072 4077.
59. Todryk SM, Bejon P, Mwangi T, et al. Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans. PLoS ONE 2008 3 : e2027.
60. Bejon P, Mwacharo J, Kai O, et al. The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum. J Immunol 2007 179 : 4193 4201.
61. Kurtis JD, Hollingdale MR, Luty AJ, Lanar DE, Krzych U Duffy PE. Pre-erythrocytic immunity to Plasmodium falciparum: the case for an LSA-1 vaccine. Trends Parasitol 2001 17 : 219 223.
62. Luty AJ, Lell B, Schmidt-Ott R, et al. Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect Dis 1999 179 : 980 988.
63. Kurtis JD, Lanar DE, Opollo M Duffy PE. Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum. Infect Immun 1999 67 : 3424 3429.
64. John CC, Tande AJ, Moormann AM, et al. Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children. J Infect Dis 2008 197 : 519 526.